99 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
in $5.0 million in gross proceeds.
R&D Expenses: Research and development expenses for the full year 2023 were $6.1 million, compared to $2.7 million … expenses
Research and development - licenses acquired
General and administrative
Loss from operations
Interest income
Financing costs – warrant
8-K
ATXI
Avenue Therapeutics Inc
15 Mar 24
Other Events
7:15am
research and development and manufacturing capabilities; expectations for generating revenue or becoming profitable on a sustained basis; expectations
DEF 14C
ATXI
Avenue Therapeutics Inc
29 Jan 24
Information statement
8:00am
. We expect our research and development expenses to continue to be significant in connection with our continued investment in our drug candidates
PRE 14C
ATXI
Avenue Therapeutics Inc
17 Jan 24
Preliminary information
5:05pm
, 2022, we had an accumulated deficit of approximately $91.6 million and $80.6 million, respectively. We expect our research and development expenses
8-K
EX-99.1
xttk5v1pbzpcdkvbfeph
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
lgz72
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:19pm
8-K
EX-99.1
jeara 8tkbo1ehat4
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
EX-99.2
yy1jsqnb995db
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-99.1
5wm9w642q
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
frl wonykk
2 Nov 23
Prospectus supplement with pricing info
9:00am
8-K
EX-99.1
pzw8vml3qy0 4w0
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm
8-K
2m5mufe0dw0n8o
21 Jul 23
Other Events
4:37pm
8-K
51j6y
22 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm